Preparation & Measurement Guide

GHK-CU 100mg Dosage Protocol

Preparation, measurement, commonly documented protocol ranges, and storage for a GHK-CU 100mg vial.

Research use only Educational summary of a commonly documented convention. Not approved for human use.
Vial Size GHK-CU 100mg
Preparation 2mL bacteriostatic water
Concentration 50mg/mL after preparation
Documented Convention 1-2mg, five days weekly

1. Preparation and Measurement

GHK-CU 100mg With 2mL of Diluent

Add 2mL of bacteriostatic water to the vial. The resulting concentration is 50mg/mL. On a U-100 syringe, each unit contains 500mcg.

100mg / 2mL = 50mg/mL
1 U-100 unit = 0.01mL = 500mcg

Preparation

  1. Draw 2mL of bacteriostatic water using sterile equipment.
  2. Let the liquid run slowly down the inside wall of the vial.
  3. Gently swirl until dissolved. Do not shake.
  4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in circulated vial protocols. Frequency: five days per week.

Period Documented amount Measurement
Weeks 1-2 1mg once daily, five days per week 0.02mL / 2 units
Weeks 3-4 1.5mg once daily, five days per week 0.03mL / 3 units
Weeks 5-8 2mg once daily, five days per week 0.04mL / 4 units

Vial estimate: One 100mg vial contains approximately 100 administrations at the first listed amount or 50 at the final listed amount.

Practical Notes

  • The table applies only to this vial prepared with exactly 2mL.
  • Some entries are very small measurements; account for the accuracy of the measuring device.
  • Record the amount, date, and preparation used.

3. Supplies Needed

  • GHK-CU 100mg vial.
  • 2mL of bacteriostatic water per vial.
  • Sterile U-100 syringes.
  • Alcohol swabs.
  • Sharps container.

4. Storage and Handling

  • Keep unopened vials cool, dry, dark, and protected from moisture.
  • After preparation, refrigerate at 2-8 degrees C.
  • Protect from light and avoid repeated freeze-thaw cycles.
  • Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

GHK-Cu has been studied in wound, tissue-remodelling, gene-expression, and skin research. Much of the literature uses topical, cell, or animal models rather than injectable human protocols.

GHK-Cu is not approved as an injectable therapeutic drug. The table records a circulated vial convention only.

Primary Research and Regulatory References

  1. Copper peptide tissue-remodelling review
  2. GHK-Cu gene-expression research
  3. Copper peptide wound-healing study

Research Materials

Review GHK-CU 100mg Product Information

← Back to Dosage Protocols

Research-use disclaimer: GHK-CU 100mg products sold by Vialcrest are intended strictly for laboratory research. They are not intended for human consumption, injection, therapeutic use, medical use, diagnostic use, or veterinary use. This article documents how a commonly circulated or published convention is described for educational comparison. It does not endorse that convention, establish safety or efficacy, or provide medical advice.